| Assay ID | Title | Year | Journal | Article |
|---|
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID127751 | Plasma cholesterol level was evaluated in Swiss white mice treated with 20 mg/kg/day of ip administration for 14 days | 2001 | Bioorganic & medicinal chemistry letters, Oct-22, Volume: 11, Issue:20
| Microwave assisted synthesis of N-arylphthalamic acids with hyperlipidemic activity. |
| AID140341 | Plasma triglyceride level was evaluated in Swiss white mice treated with 20 mg/kg/day of ip administration for 14 days | 2001 | Bioorganic & medicinal chemistry letters, Oct-22, Volume: 11, Issue:20
| Microwave assisted synthesis of N-arylphthalamic acids with hyperlipidemic activity. |
| AID34780 | Inhibition of pig kidney aldose reductase (ALR2) | 2003 | Journal of medicinal chemistry, Dec-18, Volume: 46, Issue:26
| Rational design of an indolebutanoic acid derivative as a novel aldose reductase inhibitor based on docking and 3D QSAR studies of phenethylamine derivatives. |
| AID129085 | Animal body weight was evaluated in Swiss white mice before treatment with the compound | 2001 | Bioorganic & medicinal chemistry letters, Oct-22, Volume: 11, Issue:20
| Microwave assisted synthesis of N-arylphthalamic acids with hyperlipidemic activity. |
| AID140340 | Plasma triglyceride level was evaluated in Swiss white mice before treatment with the compound | 2001 | Bioorganic & medicinal chemistry letters, Oct-22, Volume: 11, Issue:20
| Microwave assisted synthesis of N-arylphthalamic acids with hyperlipidemic activity. |
| AID127750 | Plasma cholesterol level was evaluated in Swiss white mice before treatment with the compound | 2001 | Bioorganic & medicinal chemistry letters, Oct-22, Volume: 11, Issue:20
| Microwave assisted synthesis of N-arylphthalamic acids with hyperlipidemic activity. |
| AID129086 | Animal body weight was evaluated in Swiss white mice treated with 20 mg/kg/day of ip administration for 14 days | 2001 | Bioorganic & medicinal chemistry letters, Oct-22, Volume: 11, Issue:20
| Microwave assisted synthesis of N-arylphthalamic acids with hyperlipidemic activity. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |